APA (7th ed.) Citation

A, E., S, R., J, B., C, R., S, D., S, H., . . . S, K. (2013). Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers. EMBO molecular medicine, 5(8), 1180. https://doi.org/10.1002/emmm.201202034

Chicago Style (17th ed.) Citation

A, Emadali, et al. "Identification of a Novel BET Bromodomain Inhibitor-sensitive, Gene Regulatory Circuit That Controls Rituximab Response and Tumour Growth in Aggressive Lymphoid Cancers." EMBO Molecular Medicine 5, no. 8 (2013): 1180. https://doi.org/10.1002/emmm.201202034.

MLA (9th ed.) Citation

A, Emadali, et al. "Identification of a Novel BET Bromodomain Inhibitor-sensitive, Gene Regulatory Circuit That Controls Rituximab Response and Tumour Growth in Aggressive Lymphoid Cancers." EMBO Molecular Medicine, vol. 5, no. 8, 2013, p. 1180, https://doi.org/10.1002/emmm.201202034.